Not all anti-parietal cell antibody tests are equal for diagnosing pernicious anemia

Valentin Lacombe1,2,3, Geoffrey Urbanski2,4,5

  • 1Service de Médecine interne et polyvalente, 708873 Centre Hospitalier du Haut-Anjou , Château-Gontier, France.

Insights

Indirect immunofluorescence (IIF) is more specific than immunodot assays for diagnosing pernicious anemia (PA). IIF results should guide clinical decisions when diagnosing PA and assessing treatment needs.

Area of Science:

  • Immunology
  • Gastroenterology
  • Hematology

Background:

  • Pernicious anemia (PA) is a common cause of vitamin B12 deficiency requiring accurate diagnosis.
  • Anti-parietal cell antibodies (APCA) are used in PA diagnosis, but their specificity is limited.
  • Anti-intrinsic factor antibodies (IFA) are more specific but less sensitive markers.

Purpose of the Study:

  • To compare the diagnostic performance of indirect immunofluorescence (IIF) and immunodot assays for detecting APCA in PA diagnosis.
  • To evaluate the specificity and sensitivity of IIF and immunodot assays in differentiating true PA from false positives.

Main Methods:

  • Prospective enrollment of patients with vitamin B12 deficiency and APCA positivity without IFA.
  • Expert adjudication of PA diagnosis based on histology and response to oral vitamin B12.
  • Classification of patients into true PA (APCA-PA) and false positive (APCA-FP) groups for analysis.

Main Results:

  • Indirect immunofluorescence (IIF) showed higher specificity (92%) for PA diagnosis compared to immunodot assay.
  • APCA IIF positivity was significantly associated with PA (68.4% vs. 8.3%, p<0.001).
  • A higher IIF titer (≥1:80) further increased specificity to 96% and was associated with PA diagnosis (AUC 0.82).

Conclusions:

  • IIF is a more specific method than immunodot assay for diagnosing pernicious anemia.
  • IIF results should be prioritized over immunodot assays in clinical decision-making for PA diagnosis.
  • IIF can aid in determining the need for esophagogastroduodenoscopy (EGD) or interpreting inconclusive biopsy results.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502